DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Oxazepam (Oxazepam) - Summary

 

-- advertisement --

OXAZEPAM SUMMARY

OXAZEPAM CAPSULES, USP

Oxazepam is the first of a chemical series of compounds, the 3-hydroxybenzodiazepinones. A therapeutic agent providing versatility and flexibility in control of common emotional disturbances, this product exerts prompt action in a wide variety of disorders associated with anxiety, tension, agitation, and irritability, and anxiety associated with depression. In tolerance and toxicity studies on several animal species, this product reveals significantly greater safety factors than related compounds (chlordiazepoxide and diazepam) and manifests a wide separation of effective doses and doses inducing side effects.

Oxazepam is indicated for the management of anxiety disorders or for the short-term relief of the symptoms of anxiety. Anxiety or tension associated with the stress of everyday life usually does not require treatment with an anxiolytic.

Anxiety associated with depression is also responsive to oxazepam therapy.

This product has been found particularly useful in the management of anxiety, tension, agitation, and irritability in older patients.

Alcoholics with acute tremulousness, inebriation, or with anxiety associated with alcohol withdrawal are responsive to therapy.

The effectiveness of oxazepam in long-term use, that is, more than 4 months, has not been assessed by systematic clinical studies. The physician should reassess periodically the usefulness of the drug for the individual patient.

OXAZEPAM NEWS HIGHLIGHTS

Media Articles Related to Oxazepam

Early Preparation For Gustav Can Relieve Anxiety People May Face
Source: Aid / Disasters News From Medical News Today [2008.09.01]

SEROQUEL XR™ Improved Anxiety Symptoms By Day 4 In Generalised Anxiety Disorder - New Study Results Presented Today
Source: Anxiety / Stress News From Medical News Today [2008.09.01]

Genetic Predisposition May Play A Role In Anxiety Disorders
Source: Anxiety / Stress News From Medical News Today [2008.08.26]

EU Approval For Cymbalta In Generalised Anxiety Disorder
Source: Anxiety / Stress News From Medical News Today [2008.08.24]

Cymbalta Receives European Approval For The Treatment Of Generalised Anxiety Disorder
Source: Anxiety / Stress News From Medical News Today [2008.08.23]

more>>

Published Studies Related to Oxazepam

Oxazepam does not modulate the behavioral effects of d-amphetamine in humans. [2005.10]

Effects of additional oxazepam in long-term users of oxazepam. [2005.02]

Efficacy and tolerability of valerian extract LI 156 compared with oxazepam in the treatment of non-organic insomnia--a randomized, double-blind, comparative clinical study. [2002.11.25]

Effects of lorazepam and oxazepam on perceptual and procedural memory functions. [2002.11]

Intravenous flumazenil versus oxazepam tapering in the treatment of benzodiazepine withdrawal: a randomized, placebo-controlled study. [2002.10]

more>>

Clinical Trials Related to Oxazepam

The Pharmacokinetics of Zidovudine and Oxazepam Alone and in Combination in the HIV-Infected Patient [Completed]

A Placebo-Controlled Study of a Combination of Metyrapone and Oxazepam in Cocaine Addiction [Recruiting]

Discontinuation of Antipsychotics and Antidepressants Among Patients With BPSD [Completed]

Dementia Antipsychotics And Antidepressants Discontinuation Study [Not yet recruiting]

Acamprosate Initiated During Alcohol Detoxification [Active, not recruiting]

more>>

Page last updated: 2008-09-01

-- advertisement -- The American Red Cross

We comply with
HONcode standard.
Verify here.
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2008